• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

速激肽受体选择性激动剂的分子识别:结构研究的启示。

Molecular recognition of tachykinin receptor selective agonists: insights from structural studies.

机构信息

School of Life Sciences, Jawaharlal Nehru University, New Delhi-110067.

出版信息

Mini Rev Med Chem. 2013 Dec;13(14):2036-46. doi: 10.2174/13895575113139990079.

DOI:10.2174/13895575113139990079
PMID:23937231
Abstract

This Review deals essentially with the elucidation of structural features of Tachykinin family of neuropeptides, which are known to interact through three distinct GPCR subtypes, namely NK1 (Neurokinin 1), NK2 (Neurokinin 2) and NK3 (Neurokinin 3) receptors. In mammals, Tachykinins have been shown to elicit a wide array of activities such as powerful vasodilatation, hypertensive action and stimulation of extravascular smooth muscle and are known to be involved in a variety of clinical conditions including chronic pain, Parkinson's disease, Alzheimer's disease, depression, rheumatoid arthritis, irritable bowel syndrome and asthma. This broad spectrum of action of Tachykinins is attributed to the lack of selectivity of tachykinins to their receptors. All tachykinins interact with all the three-receptor subtypes with SP preferring NK1, NKA preferring NK2 and NKB preferring NK3. This lack of specificity can be accounted for by the conformational flexibility of these short, linear peptides. Hence, identification of structural features of the agonists important for receptor binding and biological activity is of great significance in unraveling the molecular mechanisms involved in tachykinin receptor activation and also in rational design of novel therapeutic agents. Understanding structure of the ligand-receptor complex and analysis of topography of the binding pocket of the tachykinin receptor is also crucial in rational design of drugs.

摘要

这篇综述主要探讨了速激肽家族神经肽的结构特征的阐明,这些神经肽已知通过三种不同的 G 蛋白偶联受体亚型(即 NK1(神经激肽 1)、NK2(神经激肽 2)和 NK3(神经激肽 3)受体)相互作用。在哺乳动物中,速激肽已被证明能引发广泛的生理活动,如强力血管扩张、高血压作用和刺激血管外平滑肌,并且已知与多种临床情况有关,包括慢性疼痛、帕金森病、阿尔茨海默病、抑郁症、类风湿性关节炎、肠易激综合征和哮喘。速激肽的这种广谱作用归因于其对受体缺乏选择性。所有速激肽都与所有三种受体亚型相互作用,SP 优先与 NK1 结合,NKA 优先与 NK2 结合,NKB 优先与 NK3 结合。这种缺乏特异性可以归因于这些短线性肽的构象灵活性。因此,确定对受体结合和生物活性重要的激动剂的结构特征对于揭示速激肽受体激活涉及的分子机制以及合理设计新型治疗剂具有重要意义。了解配体-受体复合物的结构和分析速激肽受体的结合口袋的拓扑结构对于合理设计药物也至关重要。

相似文献

1
Molecular recognition of tachykinin receptor selective agonists: insights from structural studies.速激肽受体选择性激动剂的分子识别:结构研究的启示。
Mini Rev Med Chem. 2013 Dec;13(14):2036-46. doi: 10.2174/13895575113139990079.
2
Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.速激肽对臭鼩(家麝鼩)离体回肠的收缩作用。
Neuropeptides. 2008 Oct-Dec;42(5-6):671-9. doi: 10.1016/j.npep.2008.05.002. Epub 2008 Jun 25.
3
Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.介导新生大鼠脊髓中速激肽诱发神经元去极化的受体。
Acta Biol Hung. 1996;47(1-4):129-44.
4
Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.肠道中的速激肽和速激肽受体,特别提及人类中的NK2受体。
Auton Neurosci. 2006 Jun 30;126-127:232-49. doi: 10.1016/j.autneu.2006.02.014. Epub 2006 Apr 17.
5
Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.新型哺乳动物速激肽——血激肽1的药理学特性
Br J Pharmacol. 2002 Jan;135(1):266-74. doi: 10.1038/sj.bjp.0704443.
6
Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.中枢速激肽NK3受体在新型速激肽PG-KII对大鼠结肠推进作用中的抑制效应
Eur J Pharmacol. 1999 Jul 2;376(1-2):67-71. doi: 10.1016/s0014-2999(99)00354-4.
7
Tachykinins and tachykinin receptors: structure and activity relationships.速激肽与速激肽受体:结构与活性关系
Curr Med Chem. 2004 Aug;11(15):2045-81. doi: 10.2174/0929867043364748.
8
Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.豚鼠离体胆总管中速激肽介导收缩的受体特性研究
Br J Pharmacol. 1997 Dec;122(8):1633-8. doi: 10.1038/sj.bjp.0701560.
9
Tachykinins: receptor to effector.速激肽:从受体到效应器
Int J Biochem Cell Biol. 1996 Jul;28(7):721-38. doi: 10.1016/1357-2725(96)00017-9.
10
Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.用于开发新型神经激肽-3受体选择性激动剂的速激肽肽的构效关系研究
Bioorg Med Chem. 2013 Apr 15;21(8):2413-2417. doi: 10.1016/j.bmc.2013.01.036. Epub 2013 Feb 1.

引用本文的文献

1
Substance P's Impact on Chronic Pain and Psychiatric Conditions-A Narrative Review.P 物质对慢性疼痛和精神疾病的影响——叙述性综述。
Int J Mol Sci. 2024 May 28;25(11):5905. doi: 10.3390/ijms25115905.
2
Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach.用于胰腺癌诊断和治疗的基于噬菌体的肽:替代方法。
Front Microbiol. 2023 Aug 2;14:1231503. doi: 10.3389/fmicb.2023.1231503. eCollection 2023.
3
Comparative Aspects of Structure and Function of Cnidarian Neuropeptides.刺胞动物神经肽结构与功能的比较研究
Front Endocrinol (Lausanne). 2020 May 27;11:339. doi: 10.3389/fendo.2020.00339. eCollection 2020.
4
Substance P and pain chronicity.P 物质与疼痛慢性化。
Cell Tissue Res. 2019 Jan;375(1):227-241. doi: 10.1007/s00441-018-2922-y. Epub 2018 Oct 3.
5
The role of substance P in epilepsy and seizure disorders.P物质在癫痫和发作性疾病中的作用。
Oncotarget. 2017 Sep 1;8(44):78225-78233. doi: 10.18632/oncotarget.20606. eCollection 2017 Sep 29.